< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
21 - 30 of 66
- Gene Therapy for rare inherited Arrhythmogenic Cardiomyopathy: towards a patient-centered implementation pathwayFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder perspectives on gene therapyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom11 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom1 Sep 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Patient Experience Data for Innovative TherapiesFrom31 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- NEED for rare conditions. Identification of unmet patient and societal needs in healthcare - Applicability of a framework to rare diseasesFrom2 May 2023 → 26 Mar 2024Funding: Belgian Health Care Knowledge Centre (KCE)
- Gene Therapy for treatment of rare inherited Arrhythmogenic CardiomyopathyFrom1 May 2023 → TodayFunding: HORIZON.2.1 - Health
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- European Cancer Imaging InitiativeFrom1 Jan 2023 → TodayFunding: Digital Europe Programme (DIGITAL)
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
Publications
41 - 50 of 233
- The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire.(2023)Published in: Journal of Market Access & Health PolicyISSN: 2001-6689Issue: 1Volume: 11Pages: 2217543
- Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis(2022)Published in: Frontiers in PharmacologyISSN: 1663-9812Volume: 13
- Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study(2022)Published in: Orphanet Journal of Rare DiseasesISSN: 1750-1172Issue: 1Volume: 17
- What matters most to patients with multiple myeloma? A Pan-European patient preference study(2022)Published in: Frontiers in OncologyISSN: 2234-943XVolume: 12
- Using provocative design to foster electronic informed consent innovation(2022)Published in: BMC MEDICAL INFORMATICS AND DECISION MAKINGISSN: 1472-6947Issue: 1Volume: 22
- How to select a best-value biological medicine? A practical model to support hospital pharmacists(2022)Published in: American Journal of Health-System PharmacyISSN: 1079-2082Issue: 22Volume: 79Pages: 2001 - 2011
- Challenges related to data protection in clinical research before and during the COVID-19 pandemic: An exploratory study(2022)Published in: Frontiers in MedicineISSN: 2296-858XVolume: 9
- The future regulation of artificial intelligence systems in healthcare services and medical research in the European Union(2022)Published in: Frontiers in geneticsISSN: 1664-8021Volume: 13
- Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study(2022)Published in: BMC Health Services ResearchISSN: 1472-6963Issue: 1Volume: 22
- Rethinking informed consent in the time of COVID-19: An exploratory survey(2022)Published in: Frontiers in MedicineISSN: 2296-858XVolume: 9